DIA Biosimilars 2013

AG Mednet

AG Mednet, Biovisiq team up to bring clinical trial solutions to Asian market

Wednesday, April 3, 2013 09:49 AM

Executing its mission to bring zero-delay imaging technology to clinical trials around the world, AG Mednet has signed a Master Services Agreement with Biovisiq, a Japanese imaging core laboratory (ICL), with an aim to set the new industry standard for imaging data quality, compliance and efficiency.

More... »

Cenduit: Now with Patient Reminders

AG Mednet launches cloud storage with on-demand access to clinical trial data

Wednesday, February 27, 2013 09:32 AM

To support the need for storage and streamlined access to data during and after a clinical trial, AG Mednet, quality compliance partner for image data submission and collection, has launched AG Mednet Storage—a Part 11 compliant repository with on-demand access to clinical trial image data. 

More... »

CRF Health – eCOA Forum

AG Mednet licenses Columbia University software to reduce protocol amendments, unnecessary costs

Monday, November 12, 2012 09:00 AM

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet has licensed from Columbia University advanced image analysis technology developed by Drs. Lawrence Schwartz, Binsheng Zhao and Yongqiang Tan at Columbia University Medical Center.

More... »

Icon selects AG Mednet to give trial sponsors zero-delay efficiency

Wednesday, June 27, 2012 09:23 AM

AG Mednet has signed an OEM agreement with Icon Medical Imaging, a division of Icon, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into Icon’s imaging trial offerings.

More... »

AG Mednet launches software to expedite clinical trial decision-making process

Monday, May 14, 2012 02:06 PM

More than half of all image-related clinical trial query stoppages result from preventable human errors, according to industry research. In response, AG Mednet has launched its Submission Quality & Compliance module that delivers a new layer of automated quality assurance to reduce submission error rates and bring preventable delays to zero.

More... »

CWWeekly June 30th 2008 Issue

Monday, July 7, 2008 10:32 AM

Top News

More... »

eClinical Round-Up

Tuesday, July 1, 2008 09:47 AM

During the DIA 2008 Annual Meeting held in Boston, Phase Forward announced it formed an alliance with AG Mednet to streamline the process of transporting medical imaging, such as MRIs, CAT scans and ultrasounds. The alliance calls for the combining of InForm, Phase Forward’s trial management system, and AG Mednet’s imaging transport network for better tracking and management of patient images in real time from sites to imaging experts. “Clinical trial sponsors need a way to transport patient images more quickly and efficiently for less cost, and a real-time capability to track and manage these images,” said Martin Young Phase Forward’s vice president of corporate development and marketing.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs